SYNA · SYNAPTICS Inc

The shares were sold pursuant to 10b5-1 Trading Plan dated September 12, 2025.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $114.25 to $115.03, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $115.36 to $115.75, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 12, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $114.42 to $115.36, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 4, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $115.69 to $115.92, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 4, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $113.63 to $114.58, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 12, 2025.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 4, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $114.69 to $115.63, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $143.25 to $143.38, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $138.67 to $139.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $137.32 to $138.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $139.96 to $140.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $142.19 to $143.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to a 10b5-1 Trading Plan dated March 14, 2024.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to 10b5-1 Trading Plan dated March 14, 2024.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units and performance stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units and performance stock units.

Includes 304 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units and performance stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units and performance stock units.

Includes 293 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units and performance stock units.

The shares were sold pursuant to 10b5-1 Trading Plan dated March 14, 2024.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 4, 2025.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $81.05 to $81.91, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 11, 2025.

The shares were sold pursuant to 10b5-1 Trading Plan dated March 14, 2024.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $82.53 to $83.05, inclusive. The reporting person undertakes to provide (the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to 10b5-1 Trading Plan dated March 14, 2024.

Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the settlement of restricted stock units.

The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.